146 related articles for article (PubMed ID: 12840610)
1. Theophylline for acute renal vasoconstriction associated with tacrolimus: a new indication for an old therapeutic agent?
Thomas NJ; Carcillo JA
Pediatr Crit Care Med; 2003 Jul; 4(3):392-3. PubMed ID: 12840610
[No Abstract] [Full Text] [Related]
2. Reversal of acute tacrolimus-induced renal vasoconstriction by theophylline in rats.
McLaughlin GE; Kashimawo LA; Steele BW; Kuluz JW
Pediatr Crit Care Med; 2003 Jul; 4(3):358-62. PubMed ID: 12831420
[TBL] [Abstract][Full Text] [Related]
3. Adenosine receptor antagonism in acute tacrolimus toxicity.
McLaughlin GE; Alva MD; Egea M
Nephrol Dial Transplant; 2006 Jul; 21(7):1961-5. PubMed ID: 16522656
[TBL] [Abstract][Full Text] [Related]
4. [Controversies about the use of calcineurin inhibitors in pediatric patients].
Dello Strologo L
G Ital Nefrol; 2008; 25(3):317-24. PubMed ID: 18473303
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic use of theophylline to antagonize renal effects of adenosine.
Osswald H; Gleiter C; Mühlbauer B
Clin Nephrol; 1995 Jan; 43 Suppl 1():S33-7. PubMed ID: 7781203
[TBL] [Abstract][Full Text] [Related]
6. The effect of long-term calcineurin inhibitor therapy on renal function in children after liver transplantation.
Arora-Gupta N; Davies P; McKiernan P; Kelly DA
Pediatr Transplant; 2004 Apr; 8(2):145-50. PubMed ID: 15049794
[TBL] [Abstract][Full Text] [Related]
7. Theophylline improves early allograft function in rat kidney transplantation.
Grenz A; Baier D; Petroktistis F; Wehrmann M; Köhle C; Schenk M; Sessler M; Gleiter CH; Fandrich F; Osswald H
J Pharmacol Exp Ther; 2006 May; 317(2):473-9. PubMed ID: 16410406
[TBL] [Abstract][Full Text] [Related]
8. Reversal of oliguric tacrolimus nephrotoxicity in children.
McLaughlin GE; Abitbol CL
Nephrol Dial Transplant; 2005 Jul; 20(7):1471-5. PubMed ID: 15840666
[TBL] [Abstract][Full Text] [Related]
9. [Interaction between tacrolimus and theophylline in a renal transplant recipient: a case report].
Gaïes E; Trabelsi S; Salouage I; Jebabli N; Charfi R; Lakhal M; Klouz A
Therapie; 2011; 66(6):553-4. PubMed ID: 22186080
[No Abstract] [Full Text] [Related]
10. FK 506-induced nephrotoxicity in rats.
Kumano K; Wang G; Endo T; Kuwao S
Transplant Proc; 1991 Feb; 23(1 Pt 1):512-5. PubMed ID: 1703696
[No Abstract] [Full Text] [Related]
11. Replacing calcineurin inhibitors with mTOR inhibitors in children.
Sindhi R; Seward J; Mazariegos G; Soltys K; Seward L; Smith A; Kosmach B; Venkataramanan R
Pediatr Transplant; 2005 Jun; 9(3):391-7. PubMed ID: 15910398
[TBL] [Abstract][Full Text] [Related]
12. Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?
Nashan B
Transplant Rev (Orlando); 2009 Jan; 23(1):47-52. PubMed ID: 19027616
[TBL] [Abstract][Full Text] [Related]
13. Four-year data after pediatric renal transplantation: a randomized trial of tacrolimus vs. cyclosporin microemulsion.
Filler G; Webb NJ; Milford DV; Watson AR; Gellermann J; Tyden G; Grenda R; Vondrak K; Hughes D; Offner G; Griebel M; Brekke IB; McGraw M; Balzar E; Friman S; Trompeter R
Pediatr Transplant; 2005 Aug; 9(4):498-503. PubMed ID: 16048603
[TBL] [Abstract][Full Text] [Related]
14. Avoidance of calcineurin inhibitors with use of proliferation signal inhibitors in de novo heart transplantation with renal failure.
González-Vílchez F; de Prada JA; Exposito V; García-Camarero T; Fernández-Friera L; Llano M; Ruano J; Martín-Durán R
J Heart Lung Transplant; 2008 Oct; 27(10):1135-41. PubMed ID: 18926406
[TBL] [Abstract][Full Text] [Related]
15. Comparison between effects of cyclosporine and tacrolimus on glomerular filtration rate in pediatric post-orthotopic liver transplant patients.
Loo RM; Ariyarajah V; Oh C; Shen L; Aw MM; Prabhakaran K
Pediatr Transplant; 2006 Feb; 10(1):55-9. PubMed ID: 16499588
[TBL] [Abstract][Full Text] [Related]
16. What does the CONVERT trial really tell us about conversion from calcineurin inhibitors to sirolimus?
Hanto DW; Chudzinski R
Transplantation; 2009 Jan; 87(2):164-5. PubMed ID: 19155968
[No Abstract] [Full Text] [Related]
17. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
[TBL] [Abstract][Full Text] [Related]
18. Benefit of theophylline administration in tacrolimus-induced nephrotoxicity in rats.
McLaughlin GE; Schober M; Perez M; Ruiz P; Steele BW; Abitbol C
Pediatr Nephrol; 2003 Sep; 18(9):860-4. PubMed ID: 12836095
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporine-associated nephrotoxicity is not intractable.
Loertscher R
Transplant Proc; 1987 Aug; 19(4):3486-9. PubMed ID: 3303520
[No Abstract] [Full Text] [Related]
20. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.
Schena FP; Pascoe MD; Alberu J; del Carmen Rial M; Oberbauer R; Brennan DC; Campistol JM; Racusen L; Polinsky MS; Goldberg-Alberts R; Li H; Scarola J; Neylan JF;
Transplantation; 2009 Jan; 87(2):233-42. PubMed ID: 19155978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
